13F HOLDINGS REPORT
BVF INC/IL
Quarter ended Q4 2024 · Filed February 14, 2025 · Accession 0000921895-25-000463
Total Value
$2.95B
Positions
53
Other Managers
1
Confidential Omitted
No
Holdings (53)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | MOONLAKE IMMUNOTHERAPEUTICS | MLTX | 19,751,284 | $1.07B | 36.25% |
| 2 | KYMERA THERAPEUTICS INC | KYMR | 5,161,801 | $207.7M | 7.04% |
| 3 | REVOLUTION MEDICINES INC | RVMDW | 4,181,179 | $182.9M | 6.20% |
| 4 | AXSOME THERAPEUTICS INC | AXSM | 1,388,064 | $117.4M | 3.98% |
| 5 | MIRUM PHARMACEUTICALS INC | MIRM | 2,796,513 | $115.6M | 3.92% |
| 6 | XOMA ROYALTY CORPORATION | XOMAP | 3,633,743 | $95.5M | 3.24% |
| 7 | PROTAGONIST THERAPEUTICS INC | PTGX | 1,900,015 | $73.3M | 2.49% |
| 8 | GH RESEARCH PLC | GHRS | 10,400,158 | $72.8M | 2.47% |
| 9 | CULLINAN THERAPEUTICS INC | CGEM | 5,750,683 | $70.0M | 2.37% |
| 10 | ZYMEWORKS INC | ZYME | 4,308,935 | $63.1M | 2.14% |
| 11 | SEPTERNA INC | SEPN | 2,452,024 | $56.2M | 1.90% |
| 12 | TYRA BIOSCIENCES INC | TYRA | 3,944,194 | $54.8M | 1.86% |
| 13 | AC IMMUNE SA | ACIU | 19,522,436 | $52.7M | 1.79% |
| 14 | XENCOR INC | XNCR | 2,288,760 | $52.6M | 1.78% |
| 15 | STRUCTURE THERAPEUTICS INC | GPCR | 1,771,417 | $48.0M | 1.63% |
| 16 | CELCUITY INC | CELC | 3,466,000 | $45.4M | 1.54% |
| 17 | GALAPAGOS NV | GLPGF | 1,569,422 | $43.2M | 1.46% |
| 18 | VERVE THERAPEUTICS INC | 92539P101 | 6,904,050 | $38.9M | 1.32% |
| 19 | ANNEXON INC | ANNX | 7,000,000 | $35.9M | 1.22% |
| 20 | AGIOS PHARMACEUTICALS INC | AGIO | 1,073,755 | $35.3M | 1.20% |
| 21 | 89BIO INC | 282559103 | 4,333,885 | $33.9M | 1.15% |
| 22 | OLEMA PHARMACEUTICALS INC | OLMA | 5,715,893 | $33.3M | 1.13% |
| 23 | CIDARA THERAPEUTICS INC | 171757206 | 1,092,796 | $29.4M | 1.00% |
| 24 | ELEDON PHARMACEUTICALS INC | ELDN | 6,293,282 | $25.9M | 0.88% |
| 25 | FOGHORN THERAPEUTICS INC | FHTX | 5,302,000 | $25.0M | 0.85% |
| 26 | THIRD HARMONIC BIO INC | 88427A107 | 2,372,933 | $24.4M | 0.83% |
| 27 | KURA ONCOLOGY INC | KURA | 2,567,469 | $22.4M | 0.76% |
| 28 | ALLAKOS INC | 01671P100 | 16,552,417 | $20.0M | 0.68% |
| 29 | MONTE ROSA THERAPEUTICS INC | GLUE | 2,764,471 | $19.2M | 0.65% |
| 30 | ITEOS THERAPEUTICS INC | 46565G104 | 2,325,000 | $17.9M | 0.61% |
| 31 | ESSA PHARMA INC | 29668H708 | 8,748,629 | $15.7M | 0.53% |
| 32 | 4D MOLECULAR THERAPEUTICS IN | FDMT | 2,670,642 | $14.9M | 0.50% |
| 33 | RAPT THERAPEUTICS INC | 75382E109 | 9,237,556 | $14.6M | 0.49% |
| 34 | ENGENE HOLDINGS INC | ENGNW | 2,106,037 | $14.0M | 0.47% |
| 35 | REPARE THERAPEUTICS INC | 760273102 | 10,333,600 | $13.5M | 0.46% |
| 36 | FORTE BIOSCIENCES INC | FBRX | 594,282 | $13.5M | 0.46% |
| 37 | VERASTEM INC | VSTM | 2,100,468 | $10.9M | 0.37% |
| 38 | TSCAN THERAPEUTICS INC | TCRX | 2,989,474 | $9.1M | 0.31% |
| 39 | IMMUNIC INC | IMUX | 8,902,972 | $8.9M | 0.30% |
| 40 | PALVELLA THERAPEUTICS INC NE | PVLA | 696,555 | $8.4M | 0.28% |
| 41 | AVALO THERAPEUTICS INC | AVTX | 1,036,679 | $7.7M | 0.26% |
| 42 | IKENA ONCOLOGY INC | 45175G108 | 4,006,564 | $6.6M | 0.22% |
| 43 | MOLECULAR PARTNERS AG | MOLN | 1,353,968 | $6.5M | 0.22% |
| 44 | CYTOMX THERAPEUTICS INC | CTMX | 5,228,461 | $5.4M | 0.18% |
| 45 | OVID THERAPEUTICS INC | OVID | 3,853,818 | $3.6M | 0.12% |
| 46 | SAB BIOTHERAPEUTICS INC | SABSW | 917,826 | $3.5M | 0.12% |
| 47 | VIGIL NEUROSCIENCE INC | 92673K108 | 1,813,633 | $3.1M | 0.10% |
| 48 | GLYCOMIMETICS INC | 38000Q102 | 9,544,262 | $2.4M | 0.08% |
| 49 | TENAX THERAPEUTICS INC | TENX | 339,549 | $2.1M | 0.07% |
| 50 | ELEVATION ONCOLOGY INC | 28623U101 | 2,966,836 | $1.7M | 0.06% |
| 51 | INVENTIVA SA | IVEVF | 686,040 | $1.5M | 0.05% |
| 52 | ENGENE HOLDINGS INC | ENGNW | 945,402 | $803,686 | 0.03% |
| 53 | NLS PHARMACEUTICS LTD | H57830137 | 143,676 | $303,156 | 0.01% |